These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 880481)

  • 21. Metabolism and covalent binding of [14C]toluene by human and rat liver microsomal fractions and liver slices.
    Chapman DE; Moore TJ; Michener SR; Powis G
    Drug Metab Dispos; 1990; 18(6):929-36. PubMed ID: 1981539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of aminopyrine demethylation and binding to cytochrome P-450 by its main metabolites in rat liver microsomes [proceedings].
    Bast A; Noordhoek J
    Br J Pharmacol; 1980 Jan; 68(1):121P-122P. PubMed ID: 6766766
    [No Abstract]   [Full Text] [Related]  

  • 23. Cytochrome P-450-mediated activation and irreversible binding of the antiestrogen tamoxifen to proteins in rat and human liver: possible involvement of flavin-containing monooxygenases in tamoxifen activation.
    Mani C; Kupfer D
    Cancer Res; 1991 Nov; 51(22):6052-8. PubMed ID: 1933868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolism and disposition of 3-amino-1,5-dihydro-5-methyl-1-beta-D-ribofuranosyl-1,4,5,6, 8-pentaazaacenaphthylene in the rat.
    Basseches PJ; Powis G
    Cancer Res; 1984 Sep; 44(9):3672-8. PubMed ID: 6540141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of microsomal and cytosolic fractions from rat, mouse, and hamster liver on the mutagenicity of dimethylnitrosamine in the Salmonella plate incorporation assay.
    Prival MJ; Mitchell VD
    Cancer Res; 1981 Nov; 41(11 Pt 1):4361-7. PubMed ID: 7030474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolism and binding of cyclophosphamide and its metabolite acrolein to rat hepatic microsomal cytochrome P-450.
    Marinello AJ; Bansal SK; Paul B; Koser PL; Love J; Struck RF; Gurtoo HL
    Cancer Res; 1984 Oct; 44(10):4615-21. PubMed ID: 6380709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preliminary observations on interaction of 14C-metronidazole with macromolecules in vivo and in vitro.
    Chacko M; Maru GB; Bhide SV
    Indian J Physiol Pharmacol; 1986; 30(3):199-204. PubMed ID: 3557608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NADPH-dependent covalent binding of [3H]paroxetine to human liver microsomes and S-9 fractions: identification of an electrophilic quinone metabolite of paroxetine.
    Zhao SX; Dalvie DK; Kelly JM; Soglia JR; Frederick KS; Smith EB; Obach RS; Kalgutkar AS
    Chem Res Toxicol; 2007 Nov; 20(11):1649-57. PubMed ID: 17907785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of effect of glutathione on the binding of dimethylnitrosamine to DNA in vitro.
    Prasanna HR; Raj HG; Lotlikar PD; Magee PN
    Mol Toxicol; 1987; 1(2-3):167-76. PubMed ID: 3130567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a glutathione conjugate of cambendazole formed in the presence of liver microsomes.
    Wolf DE; VandenHeuvel JA; Tyler TR; Walker RW; Koniuszy FR; Gruber V; Arison BH; Rosegay A; Jacob TA; Wolf FJ
    Drug Metab Dispos; 1980; 8(3):131-6. PubMed ID: 6104573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enzyme-mediated covalent binding of hydralazine to rat liver microsomes.
    Streeter AJ; Timbrell JA
    Drug Metab Dispos; 1983; 11(3):179-83. PubMed ID: 6135572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolism of pancreatic carcinogens N-nitroso-2,6-dimethylmorpholine and N-nitrosobis(2-oxopropyl)amine by microsomes and cytosol of hamster pancreas and liver.
    Kokkinakis DM; Scarpelli DG; Rao MS; Hollenberg PF
    Cancer Res; 1983 Dec; 43(12 Pt 1):5761-7. PubMed ID: 6640529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proceedings: An investigation of the rat in situ absorption model using practolol and propranolol.
    Taylor DC; Grundy RU
    J Pharm Pharmacol; 1975 Dec; 27 Suppl?-2():65P. PubMed ID: 2741
    [No Abstract]   [Full Text] [Related]  

  • 34. Absorption of practolol and propranolol in dog intestinal loops in situ [proceedings].
    Taylor DC; Grundy RU; Loveday BE
    J Pharm Pharmacol; 1977 Dec; 29 Suppl():51P. PubMed ID: 22683
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of the novel bibenzyl bifluranol with diethystilboestrol: effect of aromatic fluorine substitution on metabolism [proceedings].
    Chan RP; Dekanski JB; Gottfried S; Parke DV; Pope DJ
    Br J Pharmacol; 1978 Jun; 63(2):350P. PubMed ID: 667433
    [No Abstract]   [Full Text] [Related]  

  • 36. The elimination of practolol by two human subjects.
    Dring LG; Gorchein A; Mahgoub AA; Smith RL
    Br J Clin Pharmacol; 1978 Mar; 5(3):262-5. PubMed ID: 148896
    [No Abstract]   [Full Text] [Related]  

  • 37. Irreversible protein binding of [14C]-practolol metabolite(s) to hamster liver microsomes (proceedings).
    Orton TC; Lowery C; Lindup WE
    Br J Pharmacol; 1977 Jun; 60(2):319P. PubMed ID: 880481
    [No Abstract]   [Full Text] [Related]  

  • 38. Practolol metabolism. III. Irreversible binding of [14C]practolol metabolite(s) to mammalian liver microsomes.
    Orton TC; Lowery C
    J Pharmacol Exp Ther; 1981 Oct; 219(1):207-12. PubMed ID: 6793710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The distribution and irreversible tissue binding of practolol and its metabolites in the hamster [proceedings].
    Lindup WE; Longshaw S; Orton TC; Whittaker SE
    Br J Pharmacol; 1979 Jul; 66(3):504P. PubMed ID: 526773
    [No Abstract]   [Full Text] [Related]  

  • 40. Practolol: aspects of its metabolism and ocular binding in the hamster.
    Rosenbaum SE; Lindup WE; Orton TC
    Xenobiotica; 1986 Jun; 16(6):567-73. PubMed ID: 3751112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.